California Alzheimer's Disease Program
The California Alzheimer’s Disease Program (ADP) was established in 1984 to help relieve the burden and economic costs associated with Alzheimer’s Disease and related disorders (ADRD) and to assist in ultimately discovering the cause, treatment and prevention of these diseases. This program provides clinical services to persons with ADRD and their families through the California Alzheimer’s Disease Centers (CADCs), which is a network of ten state-of-the-art Centers located at university medical centers thought the State. It also oversees the Alzheimer’s Disease Research Awards, which are grants awarded to scientists engaged in the study, including the diagnosis, treatment, prevention, epidemiology, caregiving and basic science, of ADRD.
To relieve the human burden and economic cost associated with Alzheimer’s disease and related dementias and to assist in ultimately discovering the cause and treatment of these diseases through:
- Providing state-of the-art comprehensive diagnosis, treatment, and support services for individuals with memory problems;
- Improving the quality of care for persons with Alzheimer’s disease;
- Increasing and improving training and education to health care professionals, students, caregivers, and the general public;
- Increasing research into the areas of basic science, diagnosis, treatment, behavioral management, caregiving, and epidemiology;
- Translating research findings and technical advances into clinical practice, medical education, and the community.
The Alzheimer’s Disease and Related Disorders (ADRD) Research Program is solely dependent on donations from California taxpayers on their State income tax forms. The CADCs are funded 100% by the State General Fund.